Physician
Radiology
Dr. Homer A. Macapinlac, MD
|
|
Give Review
Homer A. Macapinlac works in the field of Radiology. He attended New York Medical College - Metropolitan Hospital Center. Homer A. Macapinlac, MD is a published doctor and has 75 publications published. The lastest was: 'Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy.' He is registered with Medicare.
Publications
- Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy.
- Clinical Staging of Patients with Early Esophageal Adenocarcinoma: Does FDG-PET/CT Have a Role?
- Impact of (18)F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients.
- The value of (18)F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors.
- Utility of (18)F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary.
- Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer.
- Lymphadenectomy in Locally Advanced Cervical Cancer Study (LiLACS): A phase III clinical trial comparing surgical to radiologic staging in patients with stages IB2-IVA...
- Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer.
- Anatomic Location of PET-Positive Aortocaval Nodes in Patients with Locally Advanced Cervical Cancer: Implications for Surgical Staging.
- Low-Sensitivity FDG-PET Studies: Less Common Lung Neoplasms.
- Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.
- Implementation of Automated Tube Current Modulation in PET/CT: Prospective Selection of a Noise Index and Retrospective Patient Analysis to Ensure Image Quality.
- Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer1: a prospective correlation of surgical findings with positron emission to...
- Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction ...
- Practice based evidence of the beneficial impact of PET in patients with brain tumors.
- Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.
- Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography.
- Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
- 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.
- Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results.
- Acquisition parameters for oncologic imaging with a new SPECT/multislice CT scanner.
- Average CT in PET studies of colorectal cancer patients with metastasis in the liver and esophageal cancer patients.
- Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
- NCCN task force: clinical utility of PET in a variety of tumor types.
- Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
- 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma.
- Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.
- Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer.
- Effects of respiration-averaged computed tomography on positron emission tomography/computed tomography quantification and its potential impact on gross tumor volume d...
- Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer.
- FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?
- Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.
- Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.
- Clinical applications of positron emission tomography/computed tomography treatment planning.
- Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation.
- Breast lymphoma: imaging findings of 32 tumors in 27 patients.
- Positron emission tomography imaging in nonsmall-cell lung cancer.
- Incidental finding of prostate cancer and adenomatous colon polyp in a patient with lung cancer.
- PET/CT of esophageal cancer: its role in clinical management.
- PET and PET/CT in management of the lymphomas.
- We should desist using RECIST, at least in GIST.
- Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with ima...
- Evaluation and localization of lymphatic drainage and sentinel lymph nodes in patients with head and neck melanomas by hybrid SPECT/CT lymphoscintigraphic imaging.
- Tc-99m MDP bone scintigraphy and positron emission tomography/computed tomography (PET/CT) imaging in Erdheim-Chester disease.
- Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.
- Positron emission tomography of the brain.
- Incidental findings on integrated PET/CT that do not accumulate 18F-FDG.
- Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer.
- Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographi...
- Esophageal cancer: the role of integrated CT-PET in initial staging and response assessment after preoperative therapy.
- PET/CT imaging techniques, considerations, and artifacts.
- Truncation artifact on PET/CT: impact on measurements of activity concentration and assessment of a correction algorithm.
- Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.
- FDG-PET in the evaluation of cervical cancer.
- Imatinib resistance in gastrointestinal stromal tumors.
- Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
- Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
- Integrated positron emission tomography/computed tomography in patients with non-small cell lung cancer: normal variants and pitfalls.
- Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma.
- FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls.
- CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings.
- Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT.
- A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.
- The utility of 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanoma.
- FDG PET and PET/CT imaging in lymphoma and melanoma.
- Teflon injection for vocal cord paralysis: false-positive finding on FDG PET-CT in a patient with non-small cell lung cancer.
- Peritoneal carcinomatosis: role of (18)F-FDG PET.
- Effect of respiratory gating on quantifying PET images of lung cancer.
- Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
- Defining the Role of FDG PET in Head and Neck Cancer.
- FDG-PET in Esophageal Cancer. Incremental Value over Computed Tomography.
- Differential Metabolism and Pharmacokinetics of L-[1-(11)C]-Methionine and 2-[(18)F] Fluoro-2-deoxy-D-glucose (FDG) in Androgen Independent Prostate Cancer.
- Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total L...
- What Is the Clinical Significance of FDG Unexpected Uptake in the Prostate in Patients Undergoing PET/CT for Other Malignancies?
Doctors Specialties
- Nuclear Medicine
- Radiology
Accepted Insurances
Education
-
Memorial Sloan-Kettering Cancer Center -
New York Medical College - Metropolitan Hospital Center
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467546101 |
| Last Name Of The Provider | MACAPINLAC |
| First Name Of The Provider | HOMER |
| View All |
Similar Doctors
|
|
Dr. Mona B. Bloom, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth M. Jensen Sr., MD |
|
|
Dr. Stephen B. Chiang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Goetz Benndorf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald A. Jaffe, DO |
|
|
Dr. Khaled M. Elsayes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sangeetha Kumar, MB
This Doctor is OpenDoctor Recommended.
|